Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours-Reference-Cited by-同舟云学术

Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours

Published:2020-05-22 Issue:4 Volume:18 Page:753-762
ISSN:1476-5810
Container-title:Veterinary and Comparative Oncology
language:en
Short-container-title:Vet Comp Oncol

Author:

Pastor Nieves¹,Ezquerra Luis Javier²,Santella Massimo¹,Caballé Nuria C.³,Tarazona Raquel⁴^ORCID,Durán María Esther⁵

Affiliation:

1. Veterinary Teaching Hospital University of Extremadura Cáceres Spain

2. Animal Medicine and Surgery Unit, Department of Animal Medicine, Faculty of Veterinary Medicine University of Extremadura Cáceres Spain

3. Department of Physics and Mathematics University of Alcalá, Science Faculty Alcalá de Henares Spain

4. Immunology Unit, Department of Physiology, Faculty of Veterinary Medicine University of Extremadura Cáceres Spain

5. Anatomy and Comparative Pathological Anatomy, Department of Animal Medicine, Faculty of Veterinary Medicine University of Extremadura Cáceres Spain

Funder

European Regional Development Fund

Publisher

Wiley

Subject

General Veterinary

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vco.12603

Reference49 articles.

1. Epidemiological Study of Mammary Tumors in Female Dogs Diagnosed during the Period 2002-2012: A Growing Animal Health Problem

2. Classification and Grading of Canine Mammary Tumors

3. Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study

4. Consensus for the diagnosis, prognosis and treatment of canine mammary tumors;Cassali GD;Brazilian J Vet Pathol,2011

5. Analysis of a New Histological and Molecular-Based Classification of Canine Mammary Neoplasia

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemistry Screening of Different Tyrosine Kinase Receptors in Canine Solid Tumors—Part I: Proposal of a Receptor Panel to Predict Therapies;International Journal of Molecular Sciences;2024-08-02

2. To study the utility of COX-2 as immunohistochemical prognostic marker in comparison to various histopathological parameters and TNM staging in breast carcinoma: an observational, cross-sectional study protocol;F1000Research;2024-06-18

3. Contribution of non-steroidal anti-inflammatory drugs to breast cancer treatment: In vitro and in vivo studies;Veterinary World;2024-05

4. Risk factor analysis and clinicopathological characteristics of female dogs with mammary tumours from a single-center retrospective study in Poland;Scientific Reports;2024-03-06

5. To study the utility of COX-2 as immunohistochemical prognostic marker in comparison to various histopathological parameters and TNM staging in breast carcinoma: an observational, cross-sectional study protocol;F1000Research;2023-08-30